A new mechanism of action of bisphosphonates in tumor-induced osteolysis inhibition of the effects of bone-derived growth factors on breast cancer cells

被引：0
|
作者：
Fromigué, O
Kheddoumi, N
Dumon, JC
Body, JJ
机构：
[1] Free Univ Brussels, Inst Jules Bordet, Lab Endocrinol & Bone Dis, Brussels, Belgium
[2] Free Univ Brussels, Inst Jules Bordet, Breast Canc Res, Brussels, Belgium
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B77
引用
收藏
页码：56S / 56S
页数：1
相关论文
共 50 条
  • [31] RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
    Canon, Jude
    Bryant, Rebecca
    Roudier, Martine
    Branstetter, Daniel G.
    Dougall, William C.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 771 - 780
  • [32] RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
    Jude Canon
    Rebecca Bryant
    Martine Roudier
    Daniel G. Branstetter
    William C. Dougall
    Breast Cancer Research and Treatment, 2012, 135 : 771 - 780
  • [33] Radium-223 dichloride exhibits dual mode-of-action inhibiting both tumor and tumor-induced bone growth in two osteoblastic prostate cancer models
    Suominen, Mari I.
    Fagerlund, Katja M.
    Rissanen, Jukka P.
    Konkol, Yvonne
    Morko, Jukka
    Peng, Zhiqi
    Alhoniemi, Esa
    Mumberg, Dominik
    Ziegelbauer, Karl
    Kakonen, Sanna-Maria
    Halleen, Jussi M.
    Vessella, Robert L.
    Scholz, Arne
    CANCER RESEARCH, 2015, 75
  • [34] Ginseng augments doxorubicin-induced inhibition of human breast cancer cell proliferation and tumor growth: mechanisms of action
    Murphy, Laura L.
    King, Mandy L.
    Smith, Kimberly A.
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Inhibition of breast tumor growth and abnormal angiogenesis in mice treated with endothelial cells and their progenitor mesenchymal stem cells derived from bone marrow
    Adelipour, M.
    Allameh, A.
    Tavangar, S. M.
    Hassan, Z. M.
    Soleimani, M.
    NEOPLASMA, 2016, 63 (06) : 911 - 924
  • [36] Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice
    Takehara, Masaya
    Hoshino, Tatsuya
    Namba, Takushi
    Yamakawa, Naoki
    Mizushima, Tohru
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (09) : 1124 - 1135
  • [37] Inhibitory effects of bone marrow-derived mesenchymal stem cells on tumor growth and its possible molecular mechanism
    Furusaka, Yuma
    Katahira, Yasuhiro
    Hasegawa, Hideaki
    Umezu, Tomohiro
    Mizoguchi, Izuru
    Yoneto, Toshihiko
    Yoshimoto, Takayuki
    CANCER SCIENCE, 2023, 114 : 490 - 490
  • [38] Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer
    Liu, Jian-Feng
    Deng, Wei-Wei
    Chen, Lei
    Li, Yi-Cun
    Wu, Lei
    Ma, Si-Rui
    Zhang, Wen-Feng
    Bu, Lin-Lin
    Sun, Zhi-Jun
    MOLECULAR CARCINOGENESIS, 2018, 57 (03) : 429 - 439
  • [39] 1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model
    Lu, Guangping
    Li, Jun
    Chu, Jiahui
    Jin, Shidai
    Fu, Ziyi
    Miao, Dengshun
    Yin, Yongmei
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1033 - 1039
  • [40] Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma
    Sangai, T
    Ishii, G
    Kodama, K
    Miyamoto, S
    Aoyagi, Y
    Ito, T
    Mague, J
    Sasaki, H
    Nagashima, T
    Miyazaki, M
    Ochiai, A
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (06) : 885 - 892
12345